Document:

Exhibit 10.6

 

PRIVATE PLACEMENT WARRANTS SUBSCRIPTION
AGREEMENT

 

THIS PRIVATE PLACEMENT WARRANTS SUBSCRIPTION
AGREEMENT, dated as of January 19, 2021 (as it may be amended from time to time, this “Agreement”), is
entered into by and between Oyster Enterprises Acquisition Corp., a Delaware corporation (the “Company”), and
I-Bankers Securities, Inc. (the “Purchaser”).

 

WHEREAS, the Company intends to consummate
an initial public offering of the Company’s units (the “Public Offering”), each unit consisting of one
share of the Company’s Class A common stock (“Class A Common Stock”), par value $0.0001 per
share (each, a “Share”) and one-half of one redeemable warrant, each whole warrant entitling the holder to purchase
one Share at an exercise price of $11.50 per Share (subject to adjustment), as set forth in the Company’s registration statement
on Form S-1 related to the Public Offering (the “Registration Statement”) filed with the Securities and
Exchange Commission; and

 

WHEREAS, the Purchaser has agreed to purchase
an aggregate of 300,000 warrants (or 345,000 warrants if the over-allotment option in connection with the Public Offering is exercised
in full) (the “Private Placement Warrants”), each Private Placement Warrant entitling the holder to purchase
one Share at an exercise price of $11.50 per Share (subject to adjustment), during the period commencing on the later of (i) twelve
(12) months from the date of the closing of the Public Offering and (ii) 30 days following the consummation of the Company’s
initial business combination (the “Business Combination”), as such term is defined in the Registration Statement,
and expiring on the fifth anniversary of the consummation of the Business Combination (provided that so long as the Private Placement
Warrants are held by Imperial Capital, LLC or I-Bankers Securities, Inc. or their respective designees or affiliates, Imperial
Capital, LLC or I-Bankers Securities, Inc. or their respective designees or affiliates will not be permitted to exercise such
Private Placement Warrants after the fifth anniversary of the effective date of the Registration Statement in accordance with Rule 5110(g)(8)(A) of
the Financial Industry Regulatory Authority (“FINRA”).

 

NOW THEREFORE, in consideration of the mutual
promises contained in this Agreement and other good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the parties to this Agreement hereby, intending legally to be bound, agree as follows:

 

AGREEMENT

 

Section 1. Authorization, Purchase
and Sale; Terms of the Private Placement Warrants.

 

A. Authorization of the Private
Placement Warrants. The Company has duly authorized the issuance and sale of the Private Placement Warrants to the Purchaser.

 

B. Purchase and Sale of the Private
Placement Warrants. On the date of the consummation of the Public Offering, and concurrently with the consummation thereof,
or on such earlier time and date as may be mutually agreed by the Purchaser and the Company (the “Initial Closing Date”),
the Company shall issue and sell to the Purchaser, and the Purchaser shall purchase from the Company 300,000 Private Placement
Warrants at a price of $1.00 per warrant for an aggregate purchase price of $300,000 (the “Purchase Price”),
which shall be paid by wire transfer of immediately available funds in accordance with the Company’s wiring instructions.
On the Initial Closing Date, upon payment by the Purchaser of the Purchase Price, the Company, shall either, at its option, deliver
a certificate evidencing the Private Placement Warrants purchased by the Purchaser on such date duly registered in the Purchaser’s
name to the Purchaser, or effect such delivery in book-entry form. On the date of the consummation of the closing of the over-allotment
option in connection with the Public Offering, and concurrently with the consummation thereof, or on such earlier time and date
as may be mutually agreed by the Purchaser and the Company (each such date, an “Over-allotment Closing Date”;
together with the Initial Closing Date, the “Closing Dates” and each, a “Closing Date”),
the Company shall issue and sell to the Purchaser, and the Purchaser shall purchase from the Company, up to an aggregate of 45,000
Private Placement Warrants, in the same proportion as the amount of the over-allotment option that is exercised, at a price of
$1.00 per warrant for an aggregate purchase price of up to $45,000 (if the over-allotment option in connection with the Public
Offering is exercised in full) (the “Over-allotment Purchase Price”), which shall be paid by wire transfer of
immediately available funds in accordance with the Company’s wiring instructions. On the Over-allotment Closing Date, upon
the payment by the Purchaser of the Over-allotment Purchase Price payable by it, the Company shall either, at its option, deliver
a certificate evidencing the Private Placement Warrants purchased by the Purchaser on such date duly registered in the Purchaser’s
name to the Purchaser, or effect such delivery in book-entry form.

 

     

     

    

 

C. Terms of the Private Placement
Warrants.

 

(i) The Private Placement Warrants
shall have the terms set forth in a warrant agreement to be entered into by the Company and a warrant agent, in connection with
the Public Offering (the “Warrant Agreement”).

 

(ii) At or prior to the time of the
Initial Closing Date, the Company and the Purchaser shall enter into a registration rights agreement (the “Registration
Rights Agreement”) pursuant to which the Company will grant certain registration rights to the Purchaser relating to
the Private Placement Warrants and the Shares underlying the Private Placement Warrants.

 

Section 2. Representations and Warranties
of the Company. As a material inducement to the Purchaser to enter into this Agreement and purchase the Private Placement
Warrants, the Company hereby represents and warrants to the Purchaser (which representations and warranties shall survive each
Closing Date) that:

 

A. Organization and Corporate Power.
The Company is a corporation duly incorporated, validly existing and in good standing under the laws of the State of Delaware and
is qualified to do business in every jurisdiction in which the failure to so qualify would reasonably be expected to have a material
adverse effect on the financial condition, operating results or assets of the Company. The Company possesses all requisite corporate
power and authority necessary to carry out the transactions contemplated by this Agreement and the Warrant Agreement.

 

B. Authorization; No Breach.

 

(i) The execution, delivery and performance
of this Agreement and the Private Placement Warrants have been duly authorized and approved by the Company as of each Closing Date.
This Agreement constitutes a valid and binding obligation of the Company, enforceable against the Company in accordance with its
terms, subject to bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other laws of general applicability
relating to or affecting creditors’ rights and to general equitable principles (whether considered in a proceeding in equity
or law) (the “Enforceability Exceptions”). Upon issuance in accordance with, and payment pursuant to, the terms
of the Warrant Agreement and this Agreement, the Private Placement Warrants will constitute valid and binding obligations of the
Company, enforceable against the Company in accordance with their terms, subject to the Enforceability Exceptions.

 

(ii) The execution and delivery by
the Company of this Agreement and the Private Placement Warrants, the issuance and sale of the Private Placement Warrants, the
issuance of the Shares upon exercise of the Private Placement Warrants and the fulfillment of, and compliance with, the respective
terms hereof and thereof by the Company, do not and will not as of each Closing Date (a) (A) conflict with or result
in a breach of the terms, conditions or provisions of, (B) constitute a default under, (C) result in the creation of
any lien, security interest, charge or encumbrance upon the Company’s capital stock or assets under, or (D) result in
a violation of, the certificate of incorporation or the bylaws of the Company (in effect on the date hereof or as may be amended
prior to completion of the Public Offering), or any material law, statute, rule or regulation to which the Company is subject,
or any agreement, order, judgment or decree to which the Company is subject, or (b) require any authorization, consent, approval,
exemption, action, notice, declaration or filing, in each case, by or to any court or administrative or governmental body or agency,
except for any filings required after the date hereof under federal or state securities laws.

 

C. Title to Securities. Upon
issuance in accordance with, and payment pursuant to, the terms hereof and the Warrant Agreement, the Placement Warrants will be
duly and validly issued and the Shares issuable upon exercise of the Private Placement Warrants will be duly and validly issued,
fully paid and nonassessable. On the date of issuance of the Private Placement Warrants, the Shares issuable upon exercise of the
Private Placement Warrants shall have been reserved for issuance. Upon issuance in accordance with, and payment pursuant to, the
terms hereof and the Warrant Agreement, the Purchaser will have good title to the Private Placement Warrants and the Shares issuable
upon exercise of such Private Placement Warrants, free and clear of all liens, claims and encumbrances of any kind, other than
(i) transfer restrictions hereunder and under the other agreements contemplated hereby, (ii) transfer restrictions under
federal and state securities laws, and (iii) liens, claims or encumbrances imposed due to the actions of the Purchaser.

 

    2 

     

    

 

D. Valid Issuance. The total
number of shares of all classes of capital stock which the Company has authority to issue is 111,000,000 shares of common stock
(which consist of 100,000,000 shares of Class A Common Stock and 10,000,000 shares of the Company’s Class B common
stock, par value $0.0001 per share (the “Class B Common Stock”)) and 1,000,000 shares of the Company’s
preferred stock, par value $0.0001, per share (the “Preferred Stock”). As of the date hereof, the Company has
issued and outstanding no shares of Class A Common Stock, 5,750,000 shares of Class B Common Stock (of which up to 750,000
shares are subject to forfeiture as described in the Registration Statement) and no shares of Preferred Stock. All of the issued
shares of capital stock of the Company have been duly authorized, validly issued, and are fully paid and non-assessable.

 

Section 3. Representations and Warranties
of the Purchaser. As a material inducement to the Company to enter into this Agreement and issue and sell the Private
Placement Warrants to the Purchaser, the Purchaser hereby represents and warrants to the Company (which representations and warranties
shall survive each Closing Date) that:

 

A. Organization and Requisite Authority.
The Purchaser is duly organized, validly existing and in good standing under the laws of the State of Delaware and possesses all
requisite power and authority necessary to carry out the transactions contemplated by this Agreement.

 

B. Authorization; No Breach.

 

(i) This Agreement constitutes a valid
and binding obligation of the Purchaser, enforceable against the Purchaser in accordance with its terms, except subject to the
Enforceability Exceptions.

 

(ii) The execution and delivery by
the Purchaser of this Agreement and the fulfillment of and compliance with the terms hereof by the Purchaser does not and shall
not as of each Closing Date conflict with, violate, or result in a breach by the Purchaser of the terms, conditions or provisions
of, or constitute a default under the charter or bylaws or other organizational documents of the Purchaser, or any agreement, instrument,
order, judgment or decree to which the Purchaser is subject.

 

C. Investment Representations.

 

(i) The Purchaser is acquiring the
Private Placement Warrants and, upon exercise of the Private Placement Warrants, the Shares issuable upon such exercise (the Private
Placement Warrants and such Shares, the “Securities”), for the Purchaser’s own account, for investment
purposes only and not with a view towards, or for resale in connection with, any public sale or distribution thereof.

 

(ii) The Purchaser is an “accredited
investor” as such term is defined in Rule 501(a)(3) of Regulation D under the Securities Act of 1933, as amended
(the “Securities Act”).

 

(iii) The Purchaser understands that
the Securities are being offered and will be sold to it in reliance on specific exemptions from the registration requirements of
the United States federal and state securities laws and that the Company is relying upon the truth and accuracy of, and the Purchaser’s
compliance with, the representations and warranties of the Purchaser set forth herein in order to determine the availability of
such exemptions and the eligibility of the Purchaser to acquire such Securities.

 

(iv) The Purchaser did not enter into
this Agreement as a result of any general solicitation or general advertising within the meaning of Rule 502(c) under
the Securities Act.

 

(v) The Purchaser has been furnished
with all materials relating to the business, finances and operations of the Company and materials relating to the offer and sale
of the Securities which have been requested by the Purchaser. The Purchaser has been afforded the opportunity to ask questions
of the executive officers and directors of the Company. The Purchaser understands that its investment in the Securities involves
a high degree of risk and it has sought such accounting, legal and tax advice as it has considered necessary to make an informed
investment decision with respect to the acquisition of the Securities.

 

    3 

     

    

 

(vi) The Purchaser understands that
no United States federal or state agency or any other government or governmental agency has passed on or made any recommendation
or endorsement of the Securities or the fairness or suitability of the investment in the Securities by the Purchaser nor have such
authorities passed upon or endorsed the merits of the offering of the Securities.

 

(vii) The Purchaser understands that:
(a) the Securities have not been and are not being registered under the Securities Act or any state securities laws, and may
not be offered for sale, sold, assigned or transferred unless (1) subsequently registered thereunder or (2) sold in reliance
on an exemption therefrom; and (b) except as specifically set forth in the Registration Rights Agreement, neither the Company
nor any other person is under any obligation to register the Securities under the Securities Act or any state securities laws or
to comply with the terms and conditions of any exemption thereunder. While such Purchaser understands that Rule 144 under
the Securities Act is not available for the resale of securities initially issued by shell companies (other than business combination
related shell companies) or issuers that have been at any time previously a shell company, such Purchaser understands that Rule 144
includes an exception to this prohibition if the following conditions are met: (i) the issuer of the securities that was formerly
a shell company has ceased to be a shell company; (ii) the issuer of the securities is subject to the reporting requirements
of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”); (iii) the
issuer of the securities has filed all Exchange Act reports and material required to be filed, as applicable, during the preceding
12 months (or such shorter period that the issuer was required to file such reports and materials), other than Form 8-K reports;
and (iv) at least one year has elapsed from the time that the issuer filed current Form 10 type information with the
SEC reflecting its status as an entity that is not a shell company.

 

(viii) The Purchaser understands the
high degree of risk associated with investments in the securities of companies in the development stage such as the Company, has
such knowledge and experience in financial and business matters to be able to evaluate the merits and risks of an investment in
the Securities and is able to bear the economic risk of an investment in the Securities in the amount contemplated hereunder for
an indefinite period of time. The Purchaser has adequate means of providing for its current financial needs and contingencies and
will have no current or anticipated future needs for liquidity which would be jeopardized by the investment in the Securities.
The Purchaser can afford a complete loss of its investment in the Securities.

 

Section 4. Conditions of the Purchaser’s
Obligations. The obligations of the Purchaser to purchase and pay for the Private Placement Warrants are subject to the
fulfillment, on or before each Closing Date, of each of the following conditions:

 

A. Representations and Warranties.
The representations and warranties of the Company contained in Section 2 shall be true and correct at and as of such Closing
Date as though then made.

 

B. Performance. The Company
shall have performed and complied with all agreements, obligations and conditions contained in this Agreement that are required
to be performed or complied with by it on or before such Closing Date.

 

C. No Injunction. No litigation,
statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed
by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority over
the matters contemplated hereby, which prohibits the consummation of any of the transactions contemplated by this Agreement or
the Warrant Agreement.

 

D. Warrant Agreement and Registration
Rights Agreement. The Company shall have entered into the Warrant Agreement and the Registration Rights Agreement, each on
terms satisfactory to the Purchaser.

 

E. Corporate Consents. The Company
shall have obtained the consent of its Board of Directors authorizing the execution, delivery and performance of this Agreement
and the Warrant Agreement and the issuance and sale of the Private Placement Warrants hereunder.

 

    4 

     

    

 

Section 5. Conditions of the Company’s
Obligations. The obligations of the Company to the Purchaser under this Agreement are subject to the fulfillment, on or
before each Closing Date, of each of the following conditions:

 

A. Representations and Warranties.
The representations and warranties of the Purchaser contained in Section 3 shall be true and correct at and as of such Closing
Date as though then made.

 

B. Performance. The Purchaser
shall have performed and complied with all agreements, obligations and conditions contained in this Agreement that are required
to be performed or complied with by the Purchaser on or before such Closing Date.

 

C. Corporate Consents. The Company
shall have obtained the consent of its Board of Directors authorizing the execution, delivery and performance of this Agreement
and the Warrant Agreement and the issuance and sale of the Private Placement Warrants hereunder.

 

D. No Injunction. No litigation,
statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed
by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority over
the matters contemplated hereby, which prohibits the consummation of any of the transactions contemplated by this Agreement or
the Warrant Agreement.

 

E. Warrant Agreement. The Company
shall have entered into the Warrant Agreement on terms satisfactory to the Company.

 

Section 6. Transfer Restrictions.

 

A. Lock-Up. The Purchaser agrees
that it shall not Transfer any Private Placement Warrants and their underlying Shares until 30 days following the consummation
of the Business Combination; provided, however, that Transfers of Private Placement Warrants and their underlying Shares are permitted
(i) to the Company’s officers or directors, any affiliates or family members of any of the Company’s officers
or directors, any members of Oyster Enterprises LLC, a Delaware limited liability company (the “Sponsor”), or
any affiliates of the Sponsor, including to funds affiliated with Alden Global Capital LLC, and to limited partners of funds affiliated
with Alden Global Capital LLC, provided that any such transfers to limited partners are made on a pro rata basis pursuant
to the organizational documents of such funds and internal allocation policy; (ii) in the case of an individual, by gift to
a member of the individual’s immediate family, to a trust, the beneficiary of which is a member of the individual’s
immediate family or an affiliate of such individual, or to a charitable organization; (iii) in the case of an individual,
by virtue of the laws of descent and distribution upon death of the individual; (iv) in the case of an individual, pursuant
to a qualified domestic relations order; (v) by private sales or transfers made in connection with the consummation of the
Business Combination at prices no greater than the price at which the Private Placement Warrants or their underlying Shares, as
the case may be, were originally purchased; (vi) in the event of the Company’s liquidation prior to the completion of
the Business Combination; (vii) by virtue of the laws of the State of Delaware or the Sponsor’s limited liability company
agreement upon dissolution of the Sponsor; (viii) in the event of the Company’s completion of a liquidation, merger,
capital stock exchange, reorganization or other similar transaction which results in all of the Company’s stockholders having
the right to exchange their shares of common stock for cash, securities or other property subsequent to the Company’s completion
of the Business Combination; (ix) to the Purchaser’s affiliates or any entity controlled by the Purchaser or (x) to
a nominee or custodian of a person or entity to whom a disposition or transfer would be permissible under clauses (i) through
(ix) above; provided, however, that in the case of clauses (i) through (v) and (ix) and
(x), these permitted transferees must enter into a written agreement with the Company agreeing to be bound by the Transfer restrictions
herein.

 

For purposes of this Section, the term “Transfer”
shall mean the (i) sale of, offer to sell, contract or agreement to sell, hypothecate, pledge, grant of any option to purchase
or otherwise dispose of or agreement to dispose of, directly or indirectly, or establishment or increase of a put equivalent position
or liquidation with respect to or decrease of a call equivalent position within the meaning of Section 16 of the Exchange
Act and the rules and regulations promulgated thereunder with respect to the Private Placement Warrants or their underlying
Shares, (ii) entry into any swap or other arrangement that transfers to another, in whole or in part, any of the economic
consequences of ownership of the Private Placement Warrants or their underlying Shares, whether any such transaction is to be settled
by delivery of the Private Placement Warrants or their underlying Shares, as the case may be, in cash or otherwise, or (iii) public
announcement of any intention to effect any transaction specified in clause (i) or (ii).

 

    5 

     

    

 

B. FINRA Lock-Up. In addition to
the restrictions on transfer described in Section 6.A, the Purchaser acknowledges and agrees that the Private Placement Warrants
will be deemed compensation by FINRA and will therefore, pursuant to FINRA Rule 5110(g), be subject to lock-up for a period
of 180 days immediately following the date of effectiveness or commencement of sales in the Public Offering, subject to FINRA Rule 5110(e)(1).
Additionally, the Private Placement Warrants may not be sold, transferred, assigned, pledged or hypothecated during the 180-day
period following the effective date of the Registration Statement except to any underwriter or selected dealer participating in
the Public Offering and the bona fide officers or partners of the Purchaser and any such participating underwriter or selected
dealer. Additionally, the Private Placement Warrants will not be the subject of any hedging, short sale, derivative, put or call
transaction that would result in the economic disposition of such securities by any person for a period of 180 days immediately
following the date of effectiveness or commencement of sales in the Public Offering.

 

Section 7. Survival of Representations
and Warranties. All of the representations and warranties contained herein shall survive each Closing Date.

 

Section 8. Definitions. Terms
used but not otherwise defined in this Agreement shall have the meaning assigned to such terms in the Registration Statement.

 

Section 9. Miscellaneous.

 

A. Successors and Assigns. Except
as otherwise expressly provided herein, all covenants and agreements contained in this Agreement by or on behalf of any of the
parties hereto shall bind and inure to the benefit of the respective successors of the parties hereto whether so expressed or not.
Notwithstanding the foregoing or anything to the contrary herein, the parties may not assign this Agreement without the prior written
consent of the other party hereto, other than assignments by the Purchaser to affiliates thereof (including, without limitation,
one or more of its members).

 

B. Severability. Whenever possible,
each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable law, but if
any provision of this Agreement is held to be prohibited by or invalid under applicable law, such provision shall be ineffective
only to the extent of such prohibition or invalidity, without invalidating the remainder of this Agreement.

 

C. Counterparts. This Agreement
may be executed in counterparts, each of which when so executed shall be deemed to be an original and all of which when taken together
shall constitute one and the same instrument. The words “execution,” “signed,” “signature,”
and words of like import in this Agreement or in any other certificate, agreement or document related to this Agreement shall include
images of manually executed signatures transmitted by facsimile or other electronic format (including, without limitation, “pdf,”
 “tif” or “jpg”) and other electronic signatures (including, without limitation, DocuSign and AdobeSign).
The use of electronic signatures and electronic records (including, without limitation, any contract or other record created, generated,
sent, communicated, received, or stored by electronic means) shall be of the same legal effect, validity and enforceability as
a manually executed signature or use of a paper-based record-keeping system to the fullest extent permitted by applicable law,
including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records
Act and any other applicable law, including, without limitation, any state law based on the Uniform Electronic Transactions Act
or the Uniform Commercial Code.

 

D. Descriptive Headings; Interpretation.
The descriptive headings of this Agreement are inserted for convenience only and do not constitute a substantive part of this Agreement.
The use of the word “including” in this Agreement shall be by way of example rather than by limitation.

 

E. Governing Law. This Agreement
shall be deemed to be a contract made under the laws of the State of New York and for all purposes shall be construed in accordance
with the internal laws of the State of New York without regard to the conflicts of laws principles thereof.

 

F. Amendments. This Agreement
may not be amended, modified or waived as to any particular provision, except by a written instrument executed by all parties hereto.

 

[Signature Page Follows]

 

    6 

     

    

 

IN WITNESS WHEREOF, the parties hereto
have executed this Agreement to be effective as of the date first set forth above.

 

	 	COMPANY:
	 	 
	 	OYSTER ENTERPRISES ACQUISITION CORP.
	 	 
	 	By:	/s/ Heath B. Freeman
	 	 	Name: Heath B. Freeman 

Title: Chief Executive Officer
	 	 	 
	 	PURCHASER:
	 	 
	 	I-BANKERS SECURITIES, INC.    
	 	 	 
	 	By:	/s/ Shelley Leonard
	 	 	Name: Shelley Leonard

 Title: President

 

[Signature
Page to Private Placement Warrants Subscription Agreement]a53238868_v7xgrbk-costel

Exhibit 10.7  ACTIVE 53238868v7  This EMPLOYMENT AGREEMENT, effective as of October 26, 2020 (the “Effective Date”), is entered  into between Green Brick Partners, Inc., a Delaware corporation (the “Company”), and Richard A. Costello  (“Executive”) (each a “Party” and collectively the “Parties”) (this “Agreement”).       WHEREAS, the Executive is presently employed by the Company as Chief Financial Officer, subject to  the terms and conditions of an employment agreement dated December 11, 2018 (the “Prior Agreement”); and    WHEREAS, the Company desires to retain Executive in the position of Chief Financial Officer, and  Executive desires to accept such employment, on the terms and conditions set forth in this Agreement.     NOW, THEREFORE, in consideration of the premises and of the mutual covenants, understandings,  representations, warranties, undertakings and promises hereinafter set forth, intending to be legally bound thereby,  the Parties agree as follows:    Subject to earlier termination in accordance with Section 3 of this Agreement, Executive shall be employed  by the Company for a period commencing on the Effective Date and ending on the third anniversary of the Effective  Date (the “Employment Period”) unless the Parties mutually agree to extend the term at least ninety (90) days prior  to the end of the Employment Period. Upon Executive’s termination of employment with the Company for any  reason, at the Company’s request, Executive shall immediately resign all positions with the Company and all of its  subsidiaries and any entity in which the Company is a member, partner or stockholder (collectively, the “Company  Group”), including any position as a member of the Company’s Board of Directors (the “Board”).     2. Terms of Employment.     (a) Position. During the Employment Period, Executive shall serve as Chief Financial Officer of the  Company and will perform such duties and exercise such supervision with regard to the business of the Company as  are associated with such position, including such duties as may be prescribed from time to time by the Chief  Executive Officer of the Company (the “CEO”) and the Board. Executive shall report directly to the CEO, and if  reasonably requested by the Board, Executive hereby agrees to serve (without additional compensation) as an officer  and director of other members of the Company Group.     (b)  Duties. During the Employment Period, Executive shall have such responsibilities, duties, and  authority that are customary for Executive’s position, subject at all times to the control of the CEO and the Board,  and shall perform such services as customarily are provided by an executive of a corporation with Executive’s  position and such other services consistent with Executive’s position, as shall be assigned to Executive from time to  time by the CEO and the Board. During the Employment Period, and excluding any periods of vacation and sick  leave to which Executive is entitled, Executive agrees to devote all of Executive’s business time to the business and  affairs of the Company Group and to use Executive’s commercially reasonable efforts to perform faithfully,  effectively and efficiently Executive’s responsibilities and obligations hereunder. Executive shall be entitled to  engage in charitable and educational activities and to manage Executive’s personal and family investments, to the  extent such activities are not competitive with the business of the Company Group, do not interfere with the  performance of Executive’s duties for the Company Group and are otherwise consistent with the Company Group’s  governance policies.     (c) Compensation.    (i) Base Salary. For the period commencing on the Effective Date and ending January 15,  2021 (the “2020 Term”), Executive shall receive an annual base salary in an amount equal to four hundred thousand  dollars ($400,000) (the “2020 Base Salary”), which shall be paid pursuant to the terms and conditions of the Prior  Agreement and in accordance with the customary payroll practices of the Company and prorated for partial calendar  periods of the 2020 Term. Commencing on January 15, 2021 and until the expiration or termination of the  Employment Period, Executive shall receive an annual base salary in an amount equal to four hundred and fifty  thousand dollars ($450,000) (the “Annual Base Salary”), which shall be paid in accordance with the customary  1. Employment Period.  

 

  2    payroll practices of the Company and prorated for partial calendar years of employment. The Annual Base Salary  shall be subject to review from time to time by the Compensation Committee of the Board (the “Committee”), in its  sole discretion, for possible increase (but not decrease) and any such increased Annual Base Salary shall constitute  “Annual Base Salary” for purposes of this Agreement.     (ii) Annual Bonus. For the fiscal year ending on December 31, 2020 Executive shall be  eligible to receive a bonus (the “2020 Bonus”) under the terms of the Prior Agreement, with a target amount for the  2020 Bonus equal to four hundred thousand dollars ($400,000) (the “2020 Target”), where the 2020 Target shall be  subject to, and the 2020 Bonus paid in accordance with, the terms and conditions of the Prior Agreement. With  respect to each completed fiscal year of the Company commencing with the fiscal year ending on December 31,  2021, Executive shall be eligible to receive a bonus (the “Bonus”) under the Company’s 2014 Omnibus Equity  Incentive Plan and/or annual bonus plan, as in effect from time to time (the “Bonus Plan”), with a target amount  equal to five hundred and fifty thousand dollars ($550,000) (the “Target Bonus”), where the Target Bonus is  contingent upon the achievement of qualitative and quantitative performance goals established by the Committee  and assessed solely at the discretion of the Committee. The Bonus shall be paid in accordance with the terms of the  Company’s Bonus Plan. The Bonus may be paid partially in cash and partially in equity, as determined by the  Committee in its sole discretion. For the fiscal year ending on December 31, 2023 and, notwithstanding the  foregoing, for any year in which the Employment Period expires due to non-extension thereof (provided that  Executive is employed on the last day of such Employment Period), Executive shall be entitled to a prorated Bonus  based on the actual performance results for such year, prorated based on the number of days elapsed in such year  and payable when the Bonus would ordinarily be payable.      (iii) Benefits. During the Employment Period, Executive shall be eligible to participate in all  retirement, compensation and employee benefit plans, practices, policies and programs provided by the Company to  the extent applicable generally to senior executives of the Company (except severance plans, policies, practices, or  programs) subject to the eligibility criteria set forth therein, as such may be amended or terminated from time to  time. During the Employment Period, the Company will provide Executive with indemnification to the fullest extent  permitted by applicable law and directors’ and officers’ insurance coverage.      (iv) Expenses. During the Employment Period, Executive shall be entitled to receive  reimbursement for all reasonable business expenses incurred by Executive in performance of Executive’s duties  hereunder provided that Executive provides all necessary documentation in accordance with the Company’s  policies.    (d) Indemnification. The Company shall maintain an adequate level of directors’ and officers’ liability  insurance to protect Executive from liability related to his employment with the Company on a basis no less  favorable than that provided to any director or officer of the Company. To the extent Executive is not indemnified  by such insurance, the Company agrees to indemnify Executive for liability related to his employment with the  Company, other than any liability related to Executive’s gross negligence, willful misconduct, fraud or material  breach of this Agreement or any of the Company’s policies, to the maximum extent permitted by applicable law and  to promptly advance to Executive or Executive’s heirs or representatives related expenses upon written request with  appropriate documentation of such expense upon receipt of an undertaking by Executive or on Executive’s behalf to  repay such amount if it shall ultimately be determined that Executive is not entitled to be indemnified by the  Company. The Company further agrees that such indemnification and agreement to advance expenses shall survive  Executive’s resignation, termination or expiration of this Agreement, with respect to actions taken by him during his  employment with the Company, unless such actions could have been grounds for termination by the Company for  Cause.     (e) Claw-Back. The Company may claw back from Executive any Bonus and equity-based  compensation received in the prior year if the Company is required to restate financial results due to material non- compliance with any financial reporting requirements; provided, however, that notwithstanding the foregoing, the  Company shall be entitled to claw back any Bonus or equity-based compensation received by Executive,  

 

  3    irrespective of when received, that is required to be recovered pursuant to Section 954 of the Dodd-Frank Wall  Street Reform and Consumer Protection Act once the rules thereunder have been implemented.     3. Termination of Employment.     (a) Death or Disability. Executive’s employment shall terminate automatically upon Executive’s  death. If Executive becomes subject to a “Disability” (as defined below) during the Employment Period, the  Company may give Executive written notice in accordance with Sections 3(g) and 9(g) hereof of its intention to  terminate Executive’s employment. For purposes of this Agreement, “Disability” means Executive’s inability to  perform Executive’s duties hereunder by reason of any medically determinable physical or mental impairment for a  period of ninety (90) consecutive days or one hundred eighty (180) days or more in any twelve (12) month period.     (b) Cause. Executive’s employment may be terminated at any time by the Company for “Cause” (as  defined below). For purposes of this Agreement, “Cause” shall mean Executive’s (i) commission of a felony or a  crime of moral turpitude, (ii) engaging in conduct that constitutes fraud or embezzlement, (iii) engaging in conduct  that constitutes gross negligence or willful misconduct that results or could reasonably be expected to result in harm  to the Company Group’s business or reputation, (iv) breach of any material terms of Executive’s employment,  including this Agreement or (v) continued willful failure to substantially perform Executive’s duties. Executive’s  employment shall not be terminated for “Cause” within the meaning of clauses (iv) and (v) above unless Executive  has been given written notice by the Company stating the basis for such intended termination and Executive is given  fifteen (15) days to cure, to the extent curable, the neglect or conduct that is the basis of any such claim.     (c) Termination Without Cause (other than due to death or Disability). The Company may terminate  Executive’s employment hereunder without Cause (other than due to death or Disability) at any time for any reason  or no reason upon thirty (30) days’ prior written notice.     (d) Good Reason. Executive’s employment may be terminated by Executive for Good Reason upon  the occurrence of any event or condition constituting Good Reason. For purposes of this Agreement, “Good Reason”  means any of the following actions taken by the Company without Executive’s express written consent: (i) any  material failure of the Company to fulfill its obligations under this Agreement, (ii) a material and adverse change to,  or a material reduction of, Executive’s duties and responsibilities to the Company, (iii) a material reduction in  Executive’s then current 2020 Base Salary or Annual Base Salary, as applicable (not including any diminution  related to a broader compensation reduction that is not limited to Executive specifically and that is not more than  10% in the aggregate), or (iv) the relocation of Executive’s primary office to a location more than fifty (50) miles  from the prior location, which materially increases Executive’s commute to work; provided, that any such event  shall not constitute Good Reason unless and until Executive shall have provided the Company with notice thereof no  later than thirty (30) days following the initial occurrence of such event and the Company shall have failed to  remedy such event within thirty (30) days following receipt of such notice (such 30-day period, the “Good Reason  Cure Period”). If, at the end of the Good Reason Cure Period, the event or condition that constitutes Good Reason  has not been remedied, Executive will be entitled to terminate employment for Good Reason during the 30-day  period that follows the end of the Good Reason Cure Period. If Executive does not terminate employment during  such 30-day period, Executive shall not be permitted to terminate employment for Good Reason as a result of such  event or condition.      (e) Voluntary Termination. Executive’s employment may be terminated at any time by Executive  without Good Reason upon thirty (30) days’ prior written notice.     (f) Termination as a Result of Expiration of the Employment Period. Unless otherwise agreed  between the Parties pursuant to Section 1 hereof or otherwise, Executive’s employment shall automatically  terminate upon the expiration of the Employment Period.     

 

  4    (g) Notice of Termination. Any termination by the Company for Cause or without Cause or by reason  of Disability, or by Executive for Good Reason or without Good Reason, shall be communicated by Notice of  Termination to the other Party hereto given in accordance with Section 9(g). For purposes of this Agreement, a  “Notice of Termination” means a written notice that (i) indicates the specific termination provision in this  Agreement relied upon, (ii) to the extent applicable, sets forth in reasonable detail the facts and circumstances  claimed to provide a basis for termination of Executive’s employment under the provision so indicated and (iii) if  the “Date of Termination” (as defined below) is other than the date of receipt of such notice, specifies the  termination date. The failure by Executive or the Company to set forth in the Notice of Termination any fact or  circumstance that contributes to a showing of Good Reason or Cause shall not waive any right of Executive or the  Company hereunder or preclude Executive or the Company from asserting such fact or circumstance in enforcing  Executive’s or the Company’s rights hereunder.     (h) Date of Termination. “Date of Termination” means (i) if Executive’s employment is terminated by  the Company for Cause, without Cause or by reason of Disability, or by Executive for Good Reason or without  Good Reason, the date specified in the Notice of Termination (in the case of a termination with or without Good  Reason, provided such Date of Termination is in accordance with Section 3(d) or Section 3(e) hereof), (ii) if  Executive’s employment is terminated by reason of death, the date of death, and (iii) the expiration of the  Employment Period, and the termination of Executive’s employment upon the date of such expiration.     4. Obligations of the Company.     (a) Without Cause (other than due to death or Disability); For Good Reason;. If during the  Employment Period, the Company shall terminate Executive’s employment without Cause (other than due to death  or Disability) or Executive shall terminate Executive’s employment for Good Reason, then the Company will  provide Executive with the following payments and/or benefits:     (i) The Company shall pay to Executive (A) any vested payments or benefits to which  Executive or Executive’s estate may be entitled to receive under any of the Company’s benefit plans or applicable  law, in accordance with the terms of such plans or law (B) any Bonus earned but not yet paid for any fiscal year  ended prior to the year in which the Date of Termination occurs, at such time as such Bonus is otherwise payable  and as determined in the sole discretion of the Committee; and (C) as soon as reasonably practicable but no later  than sixty (60) days following the Date of Termination in a lump sum to the extent not previously paid, (1) the  Annual Base Salary through the Date of Termination, and (2) the amount of any unpaid expense reimbursements to  which Executive may be entitled pursuant to Section 2(c)(iv) hereof (clauses (A), (B) and (C), the “Accrued  Obligations”); and     (ii) Subject to Sections 4(e) and 5(i) below, after the Date of Termination, the Company will  pay Executive severance in an amount equal to the sum of (x) Executive’s Annual Base Salary plus (y) the Target  Bonus (the “Severance Payment”). The Severance Payment shall be paid in a lump sum on the first payroll date  following the Release Deadline Date (as defined in Section 4(e)), subject to the terms and conditions in Section 4(e)  and 5(i) below.     (b) Death or Disability. If Executive’s employment shall be terminated by reason of Executive’s death  or Disability, then the Company will provide Executive with the Accrued Obligations. Thereafter, the Company  Group shall have no further obligation to Executive or Executive’s legal representatives.     (c) Cause; Other than for Good Reason. If Executive’s employment shall be terminated by the  Company for Cause or by Executive without Good Reason, then the Company will provide Executive with the  Accrued Obligations. Thereafter, the Company Group shall have no further obligation to Executive or Executive’s  legal representatives.     

 

  5    (d) Expiration of the Employment Period. If Executive’s employment terminates by reason of the  expiration of the Employment Period pursuant to Section 1 as a result of the Company’s or Executive’s non- extension, then the Company will provide Executive with the Accrued Obligations. Thereafter, the Company Group  shall have no further obligation to Executive or Executive’s legal representatives.     (e) Separation Agreement and General Release. The Company’s obligation to pay the Severance  Payment pursuant to Section 4(a) is conditioned on Executive’s or Executive’s legal representative’s executing a  separation agreement and general release of claims related to or arising from Executive’s employment with the  Company or the termination of employment, against the Company Group (and their respective officers and  directors) in a form reasonably determined by the Company, which shall be provided by the Company to Executive  within five (5) days following the Date of Termination; provided, that if such release does not become effective and  irrevocable in accordance with its terms within fifty-five (55) days following the Date of Termination (the “Release  Deadline Date”), the Company shall not have any obligation to provide the Severance Payment.    (f) Change in Control. Upon a Change in Control (as defined below), the Company will pay  Executive an amount equal to two hundred and fifty thousand dollars ($250,000), in a lump sum. Nothing in this  Section 4(f) shall be construed as precluding any other payment or benefit, in whole or in part, as provided for in this  Agreement.    (i)           Change in Control. For purposes of this Agreement, “Change in Control” means the  occurrence of any of the following events:  (1) the acquisition, directly or indirectly, by any Person or Group of Beneficial  Ownership of securities entitled to vote generally in the election of directors (the “Voting Securities”) of the  Company that represent 50% or more of the combined voting power of the Company’s then outstanding Voting  Securities, other than:  A. an acquisition by a trustee or other fiduciary holding securities under  any employee benefit plan (or related trust) sponsored or maintained by the Company or any Person controlled by  the Company or by any employee benefit plan (or related trust) sponsored or maintained by the Company or any  Person controlled by the Company, or    B. an acquisition of Voting Securities by a corporation owned, directly or  indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of the stock  of the Company, or  C. an acquisition of Voting Securities pursuant to a transaction described  in Section 4(f)(i)(3) below that would not be a Change in Control under Section 4(f)(i)(3);     (2) individuals who, as of the Effective Date, constitute the Board (the “Incumbent  Board”) cease for any reason to constitute at least a majority of the Board; provided, however, that any individual  becoming a director subsequent to such date whose election, or nomination for election by the Company’s  stockholders, was approved by a vote of at least two-thirds of the directors then comprising the Incumbent Board  shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this  purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened election  contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or  consents by or on behalf of a Person (including, without limitation, by reason of any agreement intended to avoid or  settle any election contest or solicitation of proxies or consents) other than the Board;     (3) the consummation by the Company (whether directly involving the Company or  indirectly involving the Company through one or more intermediaries) of (x) a merger, consolidation,  reorganization, or business combination or (y) a sale or other disposition of all or substantially all of the Company’s  assets or (z) the acquisition of assets or stock of another entity, in each case, other than a transaction     

 

  6    a. which results in the Company’s Voting Securities outstanding  immediately before the transaction continuing to represent (either by remaining outstanding or by being converted  into Voting Securities of the Company or the Person that, as a result of the transaction, controls, directly or  indirectly, the Company or owns, directly or indirectly, all or substantially all of the Company’s assets or otherwise  succeeds to the business of the Company (the Company or such Person, the “Successor Entity”)), directly or  indirectly, at least 50% of the combined voting power of the Successor Entity’s outstanding Voting Securities  immediately after the transaction, and      b. after which no Person or Group beneficially owns (individually or  collectively) Voting Securities representing 50% or more of the combined voting power of the Successor Entity; or     (4) a liquidation or dissolution of the Company.     For purposes of clause 4(f)(i)(1) above, the calculation of voting power shall be made as if the date of the acquisition  were a record date for a vote of the Company’s stockholders, and for purposes of clause 4(f)(i)(3) above, the  calculation of voting power shall be made as if the date of the consummation of the transaction were a record date  for a vote of the Company’s stockholders.      (ii) For purposes of the preceding definition, the terms “Person,” “Group,” “Beneficial  Owner,” and “Beneficial Ownership” have the meanings used in the Securities Exchange Act of 1934, as amended,  and the regulations thereunder. Notwithstanding the foregoing, (1) Persons shall not be considered to be acting as a  Group solely because they purchase or own stock of the Company at the same time, or as a result of the same public  offering, (2) however, Persons will be considered to be acting as Group if they are owners of a corporation that  enters into a merger, consolidation, purchase or acquisition of stock, or similar business transaction, with the  Company, and (3) if a Person, including an entity, owns stock both in the Company and in a corporation that enters  into a merger, consolidation, purchase or acquisition of stock, or similar transaction, with the Company, such  stockholders shall be considered to be acting as a Group with other stockholders only with respect to the ownership  in the corporation before the transaction.          5. Restrictive Covenants.     (a) Non-Solicitation. In consideration of Executive’s employment and receipt of payments hereunder,  during the period commencing on the Effective Date and ending twelve (12) months after the Date of Termination  (the “Restricted Period”), Executive shall not directly, or indirectly through another person or entity, (x) induce or  attempt to induce any employee, representative, agent or consultant of any member of the Company Group to leave  the employ or services of the Company Group, or in any way interfere with the relationship between any member of  the Company Group and any employee, representative, agent or consultant thereof, (y) hire any person who was an  employee, representative, agent or consultant of any member of the Company Group at any time during the twelve  (12) month period immediately prior to the date on which such hiring would take place or (z) directly or indirectly  call on, solicit or service any customer, supplier, licensee, licensor, representative, agent or other business relation of  any member of the Company Group in order to induce or attempt to induce such person or entity to cease doing  business with, or reduce the amount of business conducted with, any member of the Company Group, or in any way  interfere with the relationship between any such customer, supplier, licensee, licensor, representative, agent or  business relation of any member of the Company Group. No action by another person or entity shall be deemed to  be a breach of this provision unless Executive directly or indirectly assisted, encouraged or otherwise counseled  such person or entity to engage in such activity.     (b) Non-Competition. Executive acknowledges and agrees that the Company Group would be  irreparably damaged if Executive were to provide services to any person or entity competing with any member of  the Company Group or engaged in a similar business and that such competition by Executive would result in a  significant loss of goodwill by the Company Group. Therefore, in consideration of the payments and benefits  

 

  7    provided to Executive and other obligations of the Company to Executive pursuant to this Agreement, including,  without limitation, the Company’s promise and obligation to provide Executive with Confidential Information (as  defined below), Executive agrees that during the Restricted Period, Executive shall not (and shall cause each of  Executive’s affiliates not to) directly or indirectly own any interest in, manage, control, participate in (whether as an  officer, director, manager, employee, partner, equity holder, member, agent, representative or otherwise), consult  with, render services for, or in any other manner engage in any business engaged directly or indirectly, in the  Geographic Area (as defined below), in the business of the Company Group as currently conducted or proposed to  be conducted as of the Date of Termination; provided, that nothing herein shall prohibit Executive from being a  passive owner of not more than 5% of the outstanding stock of any class of a corporation which is publicly traded so  long as Executive does not actively participate in the business of such corporation. For purposes of this Agreement,  the “Geographic Area” shall mean the United States of America and any other country or territory in which the  Company Group has material business operations.      (c) Non-Disclosure; Non-Use of Confidential Information. Executive acknowledges that the  Company Group has a legitimate and continuing proprietary interest in the protection of its Confidential Information  and that it has invested substantial sums and will continue to invest substantial sums to develop, maintain and  protect such Confidential Information. Executive shall not disclose or use at any time, either during Executive’s  employment with the Company or at any time thereafter, any Confidential Information of which Executive is or  becomes aware, whether or not such information is developed by Executive, except to the extent that such disclosure  or use is directly related to and required by Executive’s performance in good faith of duties assigned to Executive by  the Company. Executive will take all appropriate steps to safeguard Confidential Information in Executive’s  possession and to protect it against disclosure, misuse, espionage, loss and theft. Executive shall deliver to the  Company at the termination of Executive’s employment with the Company, or at any time the Company may  request, all memoranda, notes, plans, records, reports, computer tapes and software and other documents and data  (and copies thereof) relating to the Confidential Information or the “Work Product” (as defined in Section 5(e)(ii))  of the business of the Company Group that Executive may then possess or have under Executive’s control. In  accordance with the Defend Trade Secrets Act, 18 U.S.C. § 1833(b), and other applicable law, nothing in this  Agreement or any other agreement or policy shall prevent Executive from, or expose Executive to criminal or civil  liability under federal or state trade secret law for, (A) directly or indirectly sharing any Company Group trade  secrets or other confidential information (except information protected by the Company’s attorney-client or work  product privilege) with an attorney or with any federal, state, or local government agencies, regulators, or officials,  for the purpose of investigating or reporting a suspected violation of law, whether in response to a subpoena or  otherwise, without notice to the Company, or (B) disclosing trade secrets in a complaint or other document filed in  connection with a legal claim, provided that the filing is made under seal.     Notwithstanding anything herein to the contrary, nothing in this Agreement shall (A) prohibit the Executive from  making reports of possible violations of federal law or regulation to any governmental agency or entity in  accordance with the provisions of and rules promulgated under Section 21F of the Securities Exchange Act of 1934  or Section 806 of the Sarbanes-Oxley Act of 2002, or of any other whistleblower protection provisions of state or  federal law or regulation, or (B) require notification or prior approval by the Company of any reporting described in  clause (A).     (d) Proprietary Rights. Executive recognizes that the Company Group possesses a legitimate and  continuing proprietary interest in all Confidential Information and Work Product and has the exclusive right and  privilege to use, protect by copyright, patent or trademark, or otherwise exploit the processes, ideas and concepts  described therein to the exclusion of Executive, except as otherwise agreed between the Company Group and  Executive in writing. Executive expressly agrees that any Work Product made or developed by Executive or  Executive’s agents during the course of Executive’s employment, including any Work Product which is based on or  arises out of Work Product, shall be the property of and inure to the exclusive benefit of the Company Group.  Executive further agrees that all Work Product developed by Executive (whether or not able to be protected by  copyright, patent or trademark) during the course of Executive’s employment with the Company, or involving the  use of the time, materials or other resources of the Company Group, shall be promptly disclosed to the Company  Group and shall become the exclusive property of the Company Group, and Executive shall execute and deliver any  and all documents necessary or appropriate to implement the foregoing.     

 

  8    (e) Certain Definitions.    (i)          As used herein, the term “Confidential Information” means information that is not  generally known to the public (but for purposes of clarity, Confidential Information shall never exclude any such  information that becomes known to the public because of Executive’s unauthorized disclosure) and that is used,  developed or obtained by the Company Group in connection with its business, including, but not limited to,  information, observations and data obtained by Executive while employed by the Company Group concerning (A)  the business or affairs of the Company Group, (B) products or services, (C) fees, costs and pricing structures, (D)  designs, (E) analyses, (F) drawings, photographs and reports, (G) computer software, including operating systems,  applications and program listings, (H) flow charts, manuals and documentation, (I) databases, (J) accounting and  business methods, (K) inventions, devices, new developments, methods and processes, whether patentable or  unpatentable and whether or not reduced to practice, (L) customers and clients and customer or client lists, (M) other  copyrightable works, (N) all production methods, processes, strategies, plans, technology and trade secrets, (O)  personnel information, and (P) all similar and related information in whatever form. Confidential Information will  not include any information that has been published in a form generally available to the public (except as a result of  Executive’s unauthorized disclosure) prior to the date Executive proposes to disclose or use such information.  Confidential Information will not be deemed to have been published or otherwise disclosed merely because  individual portions of the information have been separately published, but only if all material features comprising  such information have been published in combination.     (ii)         As used herein, the term “Work Product” means all inventions, innovations,  improvements, technical information, systems, software developments, methods, designs, analyses, drawings,  reports, service marks, trademarks, trade names, logos and all similar or related information (whether patentable or  unpatentable) that relates to the Company Group’s actual or anticipated business, research and development or  existing or future products or services and that are conceived, developed or made by Executive (whether or not  during usual business hours and whether or not alone or in conjunction with any other person) while employed by  the Company together with all patent applications, letters patent, trademark, trade name and service mark  applications or registrations, copyrights and reissues thereof that may be granted for or upon any of the foregoing.     (f) Enforcement. If Executive commits a breach of any of the provisions of this Section 5 or Section 6  below, the Company shall have the right and remedy to have the provisions specifically enforced by any court  having jurisdiction, it being acknowledged and agreed by Executive that the services being rendered hereunder to  the Company Group are of a special, unique and extraordinary character and that any such breach will cause  irreparable injury to the Company Group and that money damages will not provide an adequate remedy to the  Company Group. Such right and remedy shall be in addition to, and not in lieu of, any other rights and remedies  available to the Company at law or in equity. Accordingly, Executive consents to the issuance of an injunction,  whether preliminary or permanent, consistent with the terms of this Agreement (without posting a bond or other  security) if the Company establishes a violation of Section 5 or 6 of this Agreement.     (g) Blue Pencil. If, at any time, the provisions of this Section 5 shall be determined to be invalid or  unenforceable under any applicable law, by reason of being vague or unreasonable as to area, duration or scope of  activity, this Agreement shall be considered divisible and shall become and be immediately amended to only such  area, duration and scope of activity as shall be determined to be reasonable and enforceable by the court or other  body having jurisdiction over the matter and Executive and the Company agree that this Agreement as so amended  shall be valid and binding as though any invalid or unenforceable provision had not been included herein.     (h) EXECUTIVE ACKNOWLEDGES THAT EXECUTIVE HAS CAREFULLY READ THIS  SECTION 5 AND HAS HAD THE OPPORTUNITY TO REVIEW ITS PROVISIONS WITH ANY ADVISORS  AS EXECUTIVE CONSIDERED NECESSARY AND THAT EXECUTIVE UNDERSTANDS THIS  AGREEMENT’S CONTENTS AND SIGNIFIES SUCH UNDERSTANDING AND AGREEMENT BY SIGNING  BELOW.     

 

  9    (i) Severance Payments. In addition to the rights and remedies available to the Company under this  Agreement, and not in any way in limitation of any right or remedy otherwise available to the Company Group, in  the event that Executive violates any material term of this Agreement or any other agreement between the Company  and Executive, (i) the Company’s obligation to pay the Severance Payment and Executive’s right to receive such  Severance Payment shall terminate and be of no further force or effect and (ii) Executive shall promptly repay to the  Company an amount equal to the portion of the Severance Payment previously paid to Executive.     6. Non-Disparagement.     (a)         During the Employment Period and at all times thereafter, neither Executive nor Executive’s  agents shall directly or indirectly, whether in public or private, make, publish, encourage, ratify, or authorize; or  assist or enable any other person or entity in making, authorizing, ratifying, or publishing; any statements that in any  way defame, criticize, malign, impugn, reflect negatively on, or disparage any of the Company Parties (as defined  below), or cast any of the Company Parties (as defined below) in a negative light in any manner whatsoever.  Executive also agrees that Executive will not publicly comment upon or discuss, or assist or permit any other person  or entity to publicly comment upon or discuss, any of the Company Parties with any media source or outlet (whether  negatively or otherwise), including but not limited to or with any reporters, bloggers, weblogs, websites,  newspapers, magazines, television stations or productions, radio stations, news organizations, news outlets, or  publications, or in any movie, book, or theatrical production. The foregoing shall not be violated by truthful  responses to (i) legal process or governmental inquiry or (ii) by private statements to the Company’s officers,  directors or employees; provided, that in the case of Executive, with respect to clause (ii), such statements are made  in the course of carrying out Executive’s duties pursuant to this Agreement. For purposes of this Agreement,  “Company Parties” shall include the Company Group and all of its members; and all of the past, present, and future  stockholders, members, partners, principals, investors, directors, officers, managers, benefit plans, fiduciaries,  employees, agents, attorneys, heirs, representatives, administrators, successors, and assigns of any of the foregoing  entities. Each of the Company Parties shall be a third-party beneficiary of this Agreement and shall be authorized to  enforce this Agreement in accordance with its terms.     (b)         During the Employment Period and at all times thereafter, the Company shall take all reasonable  steps to ensure that no member of the Board nor any senior executive of the Company (the “Key Persons”) shall  directly or indirectly, whether in public or private, make, publish, encourage, ratify, or authorize; or assist or enable  any other person or entity in making, authorizing, ratifying, or publishing; any statements that in any way defame,  criticize, malign, impugn, reflect negatively on, or disparage Executive, or cast Executive in a negative light in any  manner whatsoever. The foregoing shall not be violated by truthful responses to (i) legal process or governmental  inquiry or (ii) by private statements to the Company’s officers, directors or employees by Key Persons; provided,  that with respect to clause (ii), such statements are made in the course of carrying out the Key Person’s duties  pursuant to the Company.     7. Confidentiality of Agreement.     The Parties acknowledge and agree that this Agreement shall be filed with the Securities and Exchange  Commission. Notwithstanding the foregoing, the Parties agree that the discussions and correspondence that led to  this Agreement are private and confidential. Except as may be required by applicable law, regulation, or stock  exchange requirement, neither Party may disclose the above information to any other person or entity without the  prior written approval of the other Party.     

 

  10    8. Executive’s Representations, Warranties and Covenants.     (a) Executive hereby represents and warrants to the Company that:     (i) Executive has all requisite power and authority to execute and deliver this Agreement and  to consummate the transactions contemplated hereby, and this Agreement has been duly executed by Executive;     (ii) the execution, delivery and performance of this Agreement by Executive does not and  will not, with or without notice or the passage of time, conflict with, breach, violate or cause a default under any  agreement, contract or instrument to which Executive is a party or any judgment, order or decree to which Executive  is subject;     (iii) Executive is not a party to or bound by any employment agreement, consulting  agreement, non-compete agreement, fee for services agreement, confidentiality agreement or similar agreement with  any other person;     (iv) upon the execution and delivery of this Agreement by the Company and Executive, this  Agreement will be a legal, valid and binding obligation of Executive, enforceable in accordance with its terms;    (v) Executive understands that the Company will rely upon the accuracy and truth of the  representations and warranties of Executive set forth herein and Executive consents to such reliance; and    (vi) as of the date of execution of this Agreement, Executive is not in breach of any of its  terms, including having committed any acts that would form the basis for a Cause termination if such act had  occurred after the Effective Date.     (b) The Company hereby represents and warrants to Executive that:     (i) the Company has all requisite power and authority to execute and deliver this Agreement  and to consummate the transactions contemplated hereby, and this Agreement has been duly executed by the  Company;     (ii) the execution, delivery and performance of this Agreement by the Company does not and  will not, with or without notice or the passage of time, conflict with, breach, violate or cause a default under any  agreement, contract or instrument to which the Company is a party or any judgment, order or decree to which the  Company is subject;     (iii) upon the execution and delivery of this Agreement by the Company and Executive, this  Agreement will be a legal, valid and binding obligation of the Company, enforceable in accordance with its terms;  and    (iv) the Company understands that Executive will rely upon the accuracy and truth of the  representations and warranties of the Company set forth herein and the Company consents to such reliance.     9. General Provisions.     (a)          Severability. It is the desire and intent of the Parties hereto that the provisions of this Agreement  be enforced to the fullest extent permissible under the laws and public policies applied in each jurisdiction in which  enforcement is sought. Accordingly, if any particular provision of this Agreement shall be adjudicated by a court of  competent jurisdiction to be invalid, prohibited or unenforceable under any present or future law, and if the rights  

 

  11    and obligations of any Party under this Agreement will not be materially and adversely affected thereby, such  provision, as to such jurisdiction, shall be ineffective, without invalidating the remaining provisions of this  Agreement or affecting the validity or enforceability of such provision in any other jurisdiction; furthermore, in lieu  of such invalid or unenforceable provision there will be added automatically as a part of this Agreement, a legal,  valid and enforceable provision as similar in terms to such invalid or unenforceable provision as may be possible.  Notwithstanding the foregoing, if such provision could be more narrowly drawn so as not to be invalid, prohibited or  unenforceable in such jurisdiction, it shall, as to such jurisdiction, be so narrowly drawn, without invalidating the  remaining provisions of this Agreement or affecting the validity or enforceability of such provision in any other  jurisdiction.     (b)         Entire Agreement and Effectiveness. Except for those terms of the Prior Agreement which are  necessary to the execution of this Agreement, effective as of the Effective Date, this Agreement embodies the  complete agreement and understanding among the Parties hereto with respect to the subject matter hereof and  supersedes and preempts any prior understandings, agreements or representations by or among the Parties, written or  oral, which may have related to the subject matter hereof in any way, with exception for those provisions of the  Prior Agreement which are necessary in determining and/or governing the 2020 Base Salary, 2020 Bonus or 2020  Target, as may be required in Sections 2(c) and 3(d) of this Agreement.      (c)          Successors and Assigns.     (i)           This Agreement is personal to Executive and without the prior written consent of the  Company shall not be assignable by Executive otherwise than by will or the laws of descent and distribution. This  Agreement shall inure to the benefit of and be enforceable by Executive’s legal representatives.     (ii)          This Agreement shall inure to the benefit of and be binding upon the Company Group  and their successors and assigns.     (d)          Governing Law. THIS AGREEMENT WILL BE GOVERNED BY AND CONSTRUED IN  ACCORDANCE WITH THE LAWS OF THE STATE OF DELAWARE, WITHOUT GIVING EFFECT TO ANY  CHOICE OF LAW OR CONFLICTING PROVISION OR RULE THAT WOULD CAUSE THE LAWS OF ANY  JURISDICTION OTHER THAN THE STATE OF DELAWARE TO BE APPLIED. IN FURTHERANCE OF THE  FOREGOING, THE INTERNAL LAW OF THE STATE OF DELAWARE WILL CONTROL THE  INTERPRETATION AND CONSTRUCTION OF THIS AGREEMENT, EVEN IF UNDER SUCH  JURISDICTION’S CHOICE OF LAW OR CONFLICT OF LAW ANALYSIS, THE SUBSTANTIVE LAW OF  SOME OTHER JURISDICTION WOULD ORDINARILY APPLY.     (e)          Enforcement.    (i)           Arbitration. Except as specifically set forth in Section 5(f) of this Agreement, in  consideration of Executive’s employment with the Company and Executive’s receipt of compensation and other  benefits under this Agreement, EXECUTIVE AGREES THAT ANY AND ALL CONTROVERSIES, CLAIMS,  OR DISPUTES WITH ANYONE (INCLUDING THE COMPANY GROUP AND ANY EMPLOYEE, OFFICER,  DIRECTOR, STOCKHOLDER OR BENEFIT PLAN OF THE COMPANY GROUP, IN THEIR CAPACITY AS  SUCH OR OTHERWISE) ARISING OUT OF, RELATING TO, OR RESULTING FROM EXECUTIVE’S  EMPLOYMENT WITH THE COMPANY OR THE TERMINATION OF EXECUTIVE’S EMPLOYMENT WITH  THE COMPANY, INCLUDING ANY BREACH OF THIS AGREEMENT, SHALL BE SUBJECT TO BINDING  ARBITRATION. Such arbitration shall take place in Dallas, Texas (unless the Parties agree in writing to a different  location), before a single arbitrator, who shall be an attorney, in accordance with the Employment Dispute  Resolution Rules of the American Arbitration Association then in effect. Executive agrees that the arbitrator shall  have the power to decide any motions brought by any party to the arbitration, including motions for summary  judgment and/or adjudication and motions to dismiss and demurrers, prior to any arbitration hearing. Executive also  agrees that the arbitrator shall have the power to award any remedies, including attorneys’ fees and costs, available  

 

  12    under applicable law. The decision and award made by the arbitrator shall be final, binding and conclusive on all  Parties hereto for all purposes, and judgment may be entered thereon in any court having jurisdiction thereof. The  Company will bear the totality of the arbitrator’s and administrative fees and costs. Each Party shall otherwise bear  its own litigation costs and expenses; provided, however, that the arbitrator shall have the discretion to award the  prevailing Party reimbursement of its reasonable attorney’s fees and costs. The arbitration shall be conducted on a  strictly confidential basis, and Executive shall not disclose the existence of a claim, the nature of a claim, any  documents, exhibits, or information exchanged or presented in connection with such a claim, or the result of any  claim (collectively, “Arbitration Materials”) to any third party, with the sole exception of Executive’s legal counsel,  who Executive shall ensure also fully complies with the confidentiality provisions of this Agreement. In the event of  any court proceeding to challenge or enforce an arbitrator’s award, the Parties hereby consent to the exclusive  jurisdiction of the state and federal courts in Dallas, Texas and agree to exclusive venue in Dallas, Texas. The  Parties hereby agree to take all steps necessary to protect the confidentiality of the Arbitration Materials in  connection with any court proceeding, agree to take all appropriate steps to file all Confidential Information (and  documents containing Confidential Information) under seal in any such proceeding where possible, and agree to the  entry of an appropriate protective order encompassing the confidentiality provisions of this Agreement.     (ii)          Remedies. All remedies hereunder are cumulative, are in addition to any other remedies  provided for by law and may, to the extent permitted by law, be exercised concurrently or separately, and the  exercise of any one remedy shall not be deemed to be an election of such remedy or to preclude the exercise of any  other remedy.     (iii)        Waiver of Jury Trial. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY  WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM  ARISING OUT OF OR RELATING TO THIS AGREEMENT.     (f)          Amendment and Waiver. The provisions of this Agreement may be amended and waived only with  the prior written consent of the Company and Executive and no course of conduct or failure or delay in enforcing the  provisions of this Agreement shall be construed as a waiver of such provisions or affect the validity, binding effect  or enforceability of this Agreement or any provision hereof.     (g)          Notices. Any notice provided for in this Agreement must be in writing and must be either  personally delivered, transmitted via telecopier, mailed by first class mail (postage prepaid and return receipt  requested) or sent by reputable overnight courier service (charges prepaid) to the recipient at the address below  indicated or at such other address or to the attention of such other person as the recipient party has specified by prior  written notice to the sending party. Notices will be deemed to have been given hereunder and received when  delivered personally, when received if transmitted via telecopier, five (5) days after deposit in the U.S. mail and one  day after deposit for overnight delivery with a reputable overnight courier service.     If to the Company, to:     Green Brick Partners, Inc.  2805 North Dallas Parkway Suite 400  Plano, TX 75093  Attention: Chief Executive Officer     with a copy (which shall not constitute notice) to:     Kara MacCullough   Greenberg Traurig, P.A.   401 East Las Olas Blvd., Suite 2000  

 

  13    Fort Lauderdale, FL 33301     If to Executive, to:     Executive’s home address most recently on file with the Company.     (h)          Withholdings Taxes. The Company may withhold from any amounts payable under this  Agreement such federal, state and local taxes as may be required to be withheld pursuant to any applicable law or  regulation.     (i)          Survival of Representations, Warranties and Agreements. All representations, warranties and  agreements contained herein shall survive any termination of Executive’s employment under this Agreement.     (j)          Descriptive Headings. The descriptive headings of this Agreement are inserted for convenience  only and do not constitute a part of this Agreement. All references to a “Section” in this Agreement are to a section  of this Agreement unless otherwise noted.     (k)         Construction. Where specific language is used to clarify by example a general statement contained  herein, such specific language shall not be deemed to modify, limit or restrict in any manner the construction of the  general statement to which it relates. The language used in this Agreement shall be deemed to be the language  chosen by the Parties to express their mutual intent, and no rule of strict construction shall be applied against any  Party.     (l)          Counterparts. This Agreement may be executed in separate counterparts, each of which is deemed  to be an original and all of which taken together constitute one and the same agreement.     (m)        Section 409A.     (i)           Compliance. Notwithstanding anything herein to the contrary, this Agreement is intended  to be interpreted and applied so that the payments and benefits set forth herein either shall either be exempt from the  requirements of Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”), or shall comply with  the requirements of Code Section 409A, and, accordingly, to the maximum extent permitted, this Agreement shall  be interpreted to be exempt from or in compliance with Code Section 409A. To the extent that the Company  determines that any provision of this Agreement would cause the Executive to incur any additional tax or interest  under Code Section 409A, the Company shall be entitled to reform such provision to attempt to comply with or be  exempt from Code Section 409A through good faith modifications. To the extent that any provision hereof is  modified in order to comply with Code Section 409A, such modification shall be made in good faith and shall, to the  maximum extent reasonably possible, maintain the original intent and economic benefit to Executive and the  Company without violating the provisions of Code Section 409A. Notwithstanding anything herein to the contrary,  in no event does the Company, the Company Group, its officers, equity holders, employees, agents, members,  directors, or representatives guarantee the exemption from or compliance with Code Section 409A and no such party  shall have any liability for failure of this Agreement to be exempt from or comply with such Code section.     (ii)          Separate Payments. Notwithstanding anything in this Agreement to the contrary, each  payment payable hereunder shall be deemed to be a payment in a series of separate payments for purposes of Code  Section 409A.     (iii)        Specified Employee. Notwithstanding any provision in this Agreement or elsewhere to  the contrary, if on the date of Executive’s termination from employment with the Company, Executive is deemed to  be a “specified employee” within the meaning of Code Section 409A and the Final Treasury Regulations using the  

 

  14    identification methodology selected by the Company from time to time, or if none, the default methodology under  Code Section 409A, any payments or benefits that constitute non-exempt deferred compensation under Code Section  409A and that are due upon a termination of Executive’s employment shall be delayed and paid or provided (or  commence, in the case of installments) on the first payroll date on or following the earlier of (i) the date which is six  (6) months and one (1) day after Executive’s termination of employment for any reason other than death, and (ii) the  date of Executive’s death, and any remaining payments and benefits shall be paid or provided in accordance with the  normal payment dates specified for such payment or benefit.     (iv)         Separation from Service. Notwithstanding anything in this Agreement or elsewhere to the  contrary, a termination of employment shall not be deemed to have occurred for purposes of any provision of this  Agreement providing for the payment of any amounts or benefits that constitute “non-qualified deferred  compensation” within the meaning of Code Section 409A upon or following a termination of Executive’s  employment unless such termination is also a “separation from service” within the meaning of Code Section 409A  and, for purposes of any such provision of this Agreement, references to a “termination,” “termination of  employment” or like terms shall mean “separation from service” and the date of such separation from service shall  be the date of termination of Executive’s employment by the Company for purposes of any such payment or  benefits.     (v)          No Designation. In no event may Executive, directly or indirectly, designate the calendar  year of any payment to be made under this Agreement or otherwise which constitutes a “deferral of compensation”  within the meaning of Code Section 409A.     (vi)         Expense Reimbursement. With regard to any provision herein that provides for  reimbursement of costs and expenses or in-kind benefits, except as permitted by Code Section 409A, (i) the right to  reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit, (ii) the amount  of expenses eligible for reimbursement, or in-kind benefits, provided during any taxable year shall not affect the  expenses eligible for reimbursement, or in-kind benefits to be provided, in any other taxable year, and (iii) such  payments shall be made on or before the last day of Executive’s taxable year following the taxable year in which the  expense was incurred.     (n)         Excess Parachute Payments. Notwithstanding anything in this Agreement to the contrary, if any of  the payments or benefits provided or to be provided by the Company or any member of the Company Group to  Executive or for Executive’s benefit pursuant to the terms of this Agreement or otherwise (“Covered Payments”) are  determined to constitute “excess parachute payments” within the meaning of Section 280G of the Code and would,  but for this Section 9(n) be subject to the excise tax imposed under Section 4999 of the Code (or any successor  provision thereto) or any similar tax imposed by state or local law or any interest or penalties with respect to such  taxes (collectively, the “Excise Tax”), then the Covered Payments shall be reduced to the minimum extent necessary  to ensure that no portion of the Covered Payments is subject to the Excise Tax. All determinations required to be  made under this Section 9(n), including whether a payment would result in an “excess parachute payment” and the  assumptions utilized in arriving at such determination, shall be made by an accounting firm selected by the  Company.        [SIGNATURE PAGE FOLLOWS]        

 

  15      IN WITNESS WHEREOF, the Parties hereto have executed this Agreement.        GREEN BRICK PARTNERS, INC.           By: /s/ James R. Brickman    Name: James R. Brickman    Title: Chief Executive Officer       EXECUTIVE           By: /s/ Richard A. Costello    Name: Richard A. Costello    Title: Chief Financial Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00319-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00319-of-00352.parquet"}]]